Filing Details
- Accession Number:
- 0000919574-17-005013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-26 16:45:10
- Reporting Period:
- 2017-06-22
- Filing Date:
- 2017-06-26
- Accepted Time:
- 2017-06-26 16:45:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012477 | Avadel Pharmaceuticals Plc | AVDL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1511900 | Ltd Fund Master Healthcare Broadfin | 20 Genesis Close Ansbacher House, Second Floor, 1344 Grand Cayman E9 KY1-1108 | No | No | Yes | No | |
| 1511901 | Broadfin Capital, Llc | 300 Park Avenue, 25Th Floor New York NY 10022 | No | No | Yes | No | |
| 1601692 | Kevin Kotler | C/O Broadfin Capital, Llc 300 Park Avenue, 25Th Floor New York NY 10022 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2017-06-22 | 100,000 | $10.80 | 4,294,464 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2017-06-23 | 161,000 | $10.60 | 4,133,464 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The Ordinary Shares are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
